Phase II Trial Of Docetaxel With Capecitabine And Bevacizumab As First-Line Chemotherapy For Patients With Metastatic Breast Cancer.
Phase of Trial: Phase II
Latest Information Update: 09 Dec 2016
At a glance
- Drugs Bevacizumab (Primary) ; Capecitabine (Primary) ; Docetaxel (Primary)
- Indications Advanced breast cancer; Male breast cancer
- Focus Therapeutic Use
- 23 Dec 2010 Actual end date (Dec 2010) added as reported by ClinicalTrials.gov.
- 23 Dec 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 05 Aug 2005 New trial record.